JOHANNESBURG (Reuters) - South Africa is not considering terminating its contract with Johnson & Johnson (J&J) for 31 million doses of its COVID-19 vaccine, Health Minister Zweli Mkhize said on Wednesday, a day after it suspended its rollout. The suspension followed U.S. federal health agencies recommending pausing use of the J&J shot because of rare cases of blood clots. The pause in the United States is expected to be a matter of days.